Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Leukemia|February 19, 2020
Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7Elena Crisà, Austin G Kulasekararaj, Vera Adema, et al.Blood|April 1, 2011
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working PartyGabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, et al.Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.Blood Advances|April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.Cancer Medicine|October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysisEnrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.Blood|December 7, 2007
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomibRoberto Piva, Bruce Ruggeri, Michael Williams, et al.Cancer|March 19, 2021
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practiceMarino Clavio, Elena Crisà, Maurizio Miglino, et al.Annals of Hematology|October 4, 2017
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter seriesAlessandra Iurlo, Sara Galimberti, Elisabetta Abruzzese, et al.Journal of Clinical Medicine|November 20, 2020
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after DiscontinuationMatteo Dragani, Giovanna Rege Cambrin, Paola Berchialla, et al.Drugs & Aging|May 18, 2013
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective studyRoberto Latagliata, Dario Ferrero, Alessandra Iurlo, et al.Pageof 5